Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Proton Rahman

Showing results (151-160 of 260) with videos related to

Pageof 26
Sort By:
Arthritis Care & Research|June 23, 2015
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III TrialArthur Kavanaugh, Lluís Puig, Alice B Gottlieb, et al.
Annals of the Rheumatic Diseases|May 7, 2021
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)Robert Bm Landewé, Lianne S Gensler, Denis Poddubnyy, et al.
Rheumatology and Therapy|September 19, 2025
Safety of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results from a Real-World Canadian SettingRegan Arendse, Proton Rahman, Philip Baer, et al.
Rheumatology and Therapy|February 28, 2024
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE StudyVinod Chandran, Louis Bessette, Carter Thorne, et al.
The Journal of Rheumatology|April 19, 2011
The Spondyloarthritis Research Consortium of Canada registry for spondyloarthritisDafna D Gladman, Proton Rahman, Richard J Cook, et al.
The Journal of Rheumatology|October 7, 2004
Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populationsTae-Hwan Kim, Proton Rahman, Jae-Bum Jun, et al.
Annals of the Rheumatic Diseases|May 6, 2009
ARTS1 polymorphisms are associated with ankylosing spondylitis in KoreansChan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, et al.
The Journal of Rheumatology|March 3, 2015
Relationship between blood plasma and synovial fluid metabolite concentrations in patients with osteoarthritisWeidong Zhang, Sergei Likhodii, Erfan Aref-Eshghi, et al.
Lancet (London, England)|June 18, 2013
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialIain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, et al.
The Journal of Rheumatology|December 17, 2015
SMAD3 Is Upregulated in Human Osteoarthritic Cartilage Independent of the Promoter DNA MethylationErfan Aref-Eshghi, Ming Liu, Seyd Babak Razavi-Lopez, et al.
Pageof 26

Showing results (151-160 of 260) with videos related to

Sort By:
Pageof 26
Arthritis Care & Research|June 23, 2015
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III TrialArthur Kavanaugh, Lluís Puig, Alice B Gottlieb, et al.
Annals of the Rheumatic Diseases|May 7, 2021
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)Robert Bm Landewé, Lianne S Gensler, Denis Poddubnyy, et al.
Rheumatology and Therapy|September 19, 2025
Safety of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results from a Real-World Canadian SettingRegan Arendse, Proton Rahman, Philip Baer, et al.
Rheumatology and Therapy|February 28, 2024
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE StudyVinod Chandran, Louis Bessette, Carter Thorne, et al.
The Journal of Rheumatology|April 19, 2011
The Spondyloarthritis Research Consortium of Canada registry for spondyloarthritisDafna D Gladman, Proton Rahman, Richard J Cook, et al.
The Journal of Rheumatology|October 7, 2004
Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populationsTae-Hwan Kim, Proton Rahman, Jae-Bum Jun, et al.
Annals of the Rheumatic Diseases|May 6, 2009
ARTS1 polymorphisms are associated with ankylosing spondylitis in KoreansChan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, et al.
The Journal of Rheumatology|March 3, 2015
Relationship between blood plasma and synovial fluid metabolite concentrations in patients with osteoarthritisWeidong Zhang, Sergei Likhodii, Erfan Aref-Eshghi, et al.
Lancet (London, England)|June 18, 2013
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialIain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, et al.
The Journal of Rheumatology|December 17, 2015
SMAD3 Is Upregulated in Human Osteoarthritic Cartilage Independent of the Promoter DNA MethylationErfan Aref-Eshghi, Ming Liu, Seyd Babak Razavi-Lopez, et al.
Pageof 26